Search Results

Return to List
Results 41–60 of 92
Sort By: Relevance | Date | Title
41.

Integrating Immunizations Into Practice

Committee Opinion Number 661, April 2016

ABSTRACT Immunization against vaccinepreventable diseases is an essential component of womens primary and preventive health care Despite the importance of vaccination and clear guidance from public health agencies rates of vaccination lag behind national goals Obstetriciangynecologists can play a ...

April 2016

PDF Format
42.

Intimate Partner Violence

Committee Opinion Number 518, February 2012

ABSTRACT Intimate partner violence IPV is a significant yet preventable public health problem that affects millions of women regardless of age economic status race religion ethnicity sexual orientation or educational background Individuals who are subjected to IPV may have lifelong consequences in...

February 2012

PDF Format
43.

Labor Induction or Augmentation and Autism

Committee Opinion Number 597, May 2014

(Reaffirmed 2016)

Abstract Functional oxytocin deficiency and a faulty oxytocin signaling pathway have been observed in conjunction with autism spectrum disorder ASD Because exogenous synthetic oxytocin commonly is administered for labor induction and augmentation some have hypothesized that synthetic oxytocin used...

May 2014

PDF Format
44.

Lead Screening During Pregnancy and Lactation

Committee Opinion Number 533, August 2012

(Reaffirmed 2016)

Abstract Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults In 2010 the Ce...

August 2012

PDF Format
45.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Committee Opinion Number 455, March 2010

(Reaffirmed 2016)

Abstract Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format
46.

Magnesium Sulfate Use in Obstetrics

Committee Opinion Number 652, January 2016

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format
47.

Management of Suboptimally Dated Pregnancies

Committee Opinion Number 688, March 2017

ABSTRACT The American College of Obstetricians and Gynecologists considers firsttrimester ultrasonography to be the most accurate method to establish or confirm gestational age Pregnancies without an ultrasonographic examination confirming or revising the estimated due date before 22 07 weeks of g...

March 2017

PDF Format
48.

Management of Women With Phenylketonuria

Committee Opinion Number 636, June 2015

(Replaces Committee Opinion Number 449, December 2009)

ABSTRACT Phenylketonuria PKU is an autosomal recessive disorder of phenylalanine Phe metabolism characterized by deficient activity of the hepatic enzyme phenylalanine hydroxylase Increased blood Phe levels are toxic to a variety of tissues particularly the developing fetal brain The mainstay of t...

June 2015

PDF Format
49.

Marijuana Use During Pregnancy and Lactation

Committee Opinion Number 637, July 2015

ABSTRACT Cannabis sativa marijuana is the illicit drug most commonly used during pregnancy The selfreported prevalence of marijuana use during pregnancy ranges from 2 to 5 in most studies A growing number of states are legalizing marijuana for medicinal or recreational purposes and its use by preg...

July 2015

PDF Format
50.

Maternal-Fetal Intervention and Fetal Care Centers

Committee Opinion Number 501, August 2011

(Reaffirmed 2014)

ABSTRACT The past two decades have yielded profound advances in the fields of prenatal diagnosis and fetal intervention Although fetal interventions are driven by a beneficencebased motivation to improve fetal and neonatal outcomes advancement in fetal therapies raises ethical issues surrounding m...

August 2011

PDF Format
51.

Maternal–Fetal Surgery for Myelomeningocele

Committee Opinion Number 550, January 2013

(Reaffirmed 2016)

ABSTRACT Myelomeningocele the most severe form of spina bifida occurs in approximately 1 in 1500 births in the United States Fetuses in whom myelomeningocele is diagnosed typically are delivered at term and are treated in the early neonatal period A recent randomized controlled trial found that fe...

January 2013

PDF Format
52.

Medically Indicated Late-Preterm and Early-Term Deliveries

Committee Opinion Number 560, April 2013

(Reaffirmed 2015)

ABSTRACT The neonatal risks of late preterm 34 0736 67 weeks of gestation and earlyterm 37 0738 67 weeks of gestation births are well established However there are a number of maternal fetal and placental complications in which either a latepreterm or earlyterm delivery is warranted The timing of ...

April 2013

PDF Format
53.

Methamphetamine Abuse in Women of Reproductive Age

Committee Opinion Number 479, March 2011

(Reaffirmed 2013)

ABSTRACT Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for gest...

March 2011

PDF Format
54.

Method for Estimating Due Date

Committee Opinion Number 611, October 2014

(Reaffirmed 2016. See also Committee Opinion No. 579)

ABSTRACT Accurate dating of pregnancy is important to improve outcomes and is a research and public health imperative As soon as data from the last menstrual period the first accurate ultrasound examination or both are obtained the gestational age and the estimated due date should be determined di...

October 2014

PDF Format
55.

Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology

Committee Opinion Number 682, December 2016

(Replaces Committee Opinion Number 581, December 2013)

ABSTRACT Genetic technology has advanced dramatically in the past few decades and its applications and use in caring for and counseling pregnant women has been transformational in the realm of prenatal diagnosis Two of the newer genetic technologies in the prenatal setting are chromosomal microarr...

December 2016

PDF Format
56.

Mode of Term Singleton Breech Delivery

Committee Opinion Number 340, July 2006

(Replaces No. 265, December 2001, Reaffirmed 2016)

ABSTRACT In light of recent studies that further clarify the longterm risks of vaginal breech delivery the American College of Obstetricians and Gynecologists recommends that the decision regarding mode of delivery should depend on the experience of the health care provider Cesarean delivery will ...

July 2006

PDF Format
57.

Moderate Caffeine Consumption During Pregnancy

Committee Opinion Number 462, August 2010

(Reaffirmed 2016)

ABSTRACT Moderate caffeine consumption less than 200 mg per day does not appear to be a major contributing factor in miscarriage or preterm birth The relationship of caffeine to growth restriction remains undetermined A final conclusion cannot be made at this time as to whether there is a correlat...

August 2010

PDF Format
58.

Multifetal Pregnancy Reduction

Committee Opinion Number 553, February 2013

(Reaffirmed 2016. Replaces Committee Opinion Number 369, June 2007)

ABSTRACT Fertility treatments have contributed significantly to the increase in multifetal pregnancies The first approach to the problem of multifetal pregnancies should be prevention and strategies to limit multifetal pregnancies especially highorder multifetal pregnancies should be practiced by ...

February 2013

PDF Format
59.

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Committee Opinion Number 376, August 2007

(Reaffirmed 2014)

ABSTRACT Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor The American College of Obstetricians and Gynecologists finds data are insufficient to recommend any changes in nalbuphine hydrochloride administration at this time Opinion Nalbuphine hydrochloride...

August 2007

PDF Format
60.

Nonmedically Indicated Early-Term Deliveries

Committee Opinion Number 561, April 2013

(Reaffirmed 2015)

ABSTRACT For certain medical conditions available data and expert opinion support optimal timing of delivery in the latepreterm or earlyterm period for improved neonatal and infant outcomes However for nonmedically indicated earlyterm deliveries such an improvement has not been demonstrated Morbid...

April 2013

PDF Format
Advertisement

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998